Suppr超能文献

[瑞典的肺移植——自1990年以来已有超过1200名患者接受移植]

[Lungtransplantation in Sweden - over 1 200 patients transplanted since 1990].

作者信息

Riise Gerdt, Magnusson Jesper, Larsson Hillevi, Hansson Lennart, Ingemansson Richard, Dellgren Göran

机构信息

adjungerad professor, överläkare, Lungmedicin, Sahlgrenska universitetssjukhuset.

med dr, överläkare, Transplantationscentrum, Sahlgrenska universitetssjukhuset.

出版信息

Lakartidningen. 2020 Aug 10;117:20015.

Abstract

Lung transplantation is an accepted treatment for end stage lung diseases and performed at two national centers in Sweden - Gothenburg and Lund. Since the start in 1990 over 1 200 patients have been transplanted.  The indications are severe progressive lung diseases with short expected survival or severe negative effects on daily life. There are several contraindications among which severe other organ disease, recent malignancy or psychiatric disease are most important.  The most common causes for lung transplantation are chronic obstructive pulmonary disease (COPD), interstitial pulmonary disease, cystic fibrosis and pulmonary hypertension.  Long term survival after 5 years is 63 %, and after 10 years 48 %, which is better than the results reported in the international registry (57 % and 36 % respectively).   Lung transplantation is today a therapy for end stage pulmonary diseases with acceptable survival results. It is likely that the number of patients will increase in the future.

摘要

肺移植是终末期肺部疾病的一种公认治疗方法,在瑞典的两个国家中心——哥德堡和隆德进行。自1990年开展以来,已有超过1200名患者接受了移植手术。其适应症为预期生存期短或对日常生活有严重负面影响的严重进展性肺部疾病。存在多种禁忌症,其中严重的其他器官疾病、近期恶性肿瘤或精神疾病最为重要。肺移植最常见的病因是慢性阻塞性肺疾病(COPD)、间质性肺疾病、囊性纤维化和肺动脉高压。5年后的长期生存率为63%,10年后为48%,这优于国际登记处报告的结果(分别为57%和36%)。如今,肺移植是一种治疗终末期肺部疾病且生存结果可接受的疗法。未来患者数量可能会增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验